Health
Study reveals new mutations that make cancer resistant to KRAS-targeted therapies – News-Medical.Net
A gene called KRAS is one of the most commonly mutated genes in all human cancers, and targeted drugs that inhibit the protein expressed by mutated KRAS have shown…
A gene called KRAS is one of the most commonly mutated genes in all human cancers, and targeted drugs that inhibit the protein expressed by mutated KRAS have shown promising results in clinical trials, with potential approvals by the U.S. Food and Drug Administration anticipated later this year.
Unfortunately, cancer cells often develop additional mutations that make them resistant to such targeted drugs, resulting in disease relapse. Now researchers led by a team at Massachusetts General Hospital…
-
General17 hours agoTributes flow after Australian Paralympic bronze medallist Nicholas Hum dies aged 32
-
General13 hours agoNT’s top year 12 achievers celebrated, with some looking to pursue teaching careers
-
General12 hours agoReuven Morrison was killed in the Bondi Beach shooting one year after warning about antisemitism
-
General20 hours agoConsent laws now protect sex workers against non-paying clients